Robin H. Kloos
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model.
Journal: Haematologica
Published: June 05, 2023
Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 11, 2020
Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model.
Journal: Haematologica
Published: November 04, 2019
Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker.
Journal: British journal of haematology
Published: July 30, 2019
A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia.
Journal: Pediatric blood & cancer
Published: May 29, 2018
A cost analysis of individualized asparaginase treatment in pediatric acute lymphoblastic leukemia.
Journal: Pediatric blood & cancer
Published: March 16, 2017
Allergic-like reactions to asparaginase: Atypical allergies without asparaginase inactivation.
Journal: Pediatric blood & cancer
Published: April 15, 2016
Hemorrhagic cystitis in a cohort of pediatric transplantations: incidence, treatment, outcome, and risk factors.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: April 17, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026